Drug Shortage Report for SANDOZ PROCTOMYXIN HC SUPPOSITORIES

Last updated on 2020-02-15 History
Report ID 102660
Drug Identification Number 02242528
Brand name SANDOZ PROCTOMYXIN HC SUPPOSITORIES
Common or Proper name PROCTOMYXIN
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) DIBUCAINE HYDROCHLORIDE HYDROCORTISONE FRAMYCETIN SULFATE ESCULIN
Strength(s) 5MG 5MG 10MG 10MG
Dosage form(s) SUPPOSITORY
Route of administration RECTAL
Packaging size 12 SUP
ATC code C05AA
ATC description AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2019-12-02
Estimated end date 2020-01-31
Actual end date 2020-02-04
Shortage status Resolved
Updated date 2020-02-15
Company comments
Health Canada comments
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2020-02-15 French Compare
v3 2020-02-15 English Compare
v2 2020-01-08 French Compare
v1 2020-01-08 English Compare